carboplatin + paclitaxel (CP)

DRUG3 trials

Sponsors

Konkuk University Medical Center, Blokhin's Russian Cancer Research Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Conditions

Breast CancerLocally Advanced Esophageal or GE Junction CancerOvarian Carcinoma

Phase 2

Camrelizumab in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-negative Breast Cancer

Not yet recruitingNCT07107217

Blokhin's Russian Cancer Research CenterBreast Cancer

Start: 2025-08-31End: 2027-12-31Target: 40Updated: 2025-08-17

Hypofractionated Definitive Chemoradiotherapy for Oesophageal Cancer

RecruitingNCT07632079

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Locally Advanced Esophageal or GE Junction Cancer

Start: 2026-04-28End: 2028-07-01Target: 60Updated: 2026-06-08

Unknown Phase

Real-World Effectiveness of PLD in Platinum- Sensitive Recurrent Ovarian Cancer

CompletedNCT03562533

Konkuk University Medical CenterOvarian Carcinoma

Start: 2018-05-17End: 2018-12-17Updated: 2019-02-28

Related Papers

Real world effectiveness and safety of pegylated liposomal doxorubicin in platinum-sensitive recurrent ovarian, fallopian, or primary peritoneal cancer: a Korean multicenter retrospective cohort study

Journal of Gynecologic Oncology2019-09-175 citations